Inhibitors
    8.
    发明授权
    Inhibitors 有权
    抑制剂

    公开(公告)号:US07803810B2

    公开(公告)日:2010-09-28

    申请号:US12045163

    申请日:2008-03-10

    CPC分类号: C07D471/04

    摘要: Compounds of formula (I), combinations and uses thereof for disease therapy, or a pharmaceutically acceptable salt or solvate thereof, including all tautomers, stereoisomers and polymorphs thereof wherein: R1 represents C2-8alkyl; C2-8alkenyl; —(C1-6alkyl)-aryl; —(C1-6alkyl)-heteroaryl; —(C1-6alkyl)-carbocyclyl; —(C1-6alkyl)-heterocyclyl; -aryl; -heteroaryl; -carbocyclyl or -heterocyclyl; wherein said aryl or heteroaryl groups may be optionally substituted by one or more substituents selected from, C1-4alkyl, C1-4-fluoroalkyl, C1-4alkoxy, C1-4-fluoroalkoxy, hydroxy, —SO2(C1-4alkyl), —SO2N(C1-4alkyl)(C1-4alkyl), —SOC1-4alkyl, —SOC3-6cycloalkyl —C(O)O(C1-4alkyl), benzyloxy and phenyl; and wherein said carbocyclyl and heterocyclyl groups may be optionally substituted by one or more substituents selected from —C1-4 alkyl, —C1-4 alkoxy, hydroxyl, halogen and oxo; R2 represents H; C1-4alkyl or halogen; R3 represents H; C1-4alkyl or halogen; and R4 represents H; C1-4alkyl or halogen.

    摘要翻译: 式(I)的化合物,其用于疾病治疗的组合和用途,或其药学上可接受的盐或溶剂合物,包括所有互变异构体,立体异构体和多晶型物,其中:R1代表C2-8烷基; C2-8烯基; - (C 1-6烷基) - 芳基; - (C 1-6烷基) - 杂芳基; - (C 1-6烷基) - 碳环基; - (C 1-6烷基) - 杂环基; 芳基 杂芳基 碳环基或杂环基; 其中所述芳基或杂芳基可以任选地被一个或多个选自C 1-4烷基,C 1-4 - 氟烷基,C 1-4烷氧基,C 1-4 - 氟烷氧基,羟基,-SO 2(C 1-4烷基),-SO 2 N (C 1-4烷基)(C 1-4烷基),-SOC 1-4烷基,-SOC 3 - 6环烷基-C(O)O(C 1-4烷基),苄氧基和苯基; 并且其中所述碳环基和杂环基可任选被一个或多个选自-C 1-4烷基,-C 1-4烷氧基,羟基,卤素和氧代的取代基取代; R2表示H; C 1-4烷基或卤素; R3表示H; C 1-4烷基或卤素; 且R 4表示H; C 1-4烷基或卤素。

    NOVEL INHIBITORS
    10.
    发明申请
    NOVEL INHIBITORS 有权
    新型抑制剂

    公开(公告)号:US20080234313A1

    公开(公告)日:2008-09-25

    申请号:US12045163

    申请日:2008-03-10

    CPC分类号: C07D471/04

    摘要: Compounds of formula (I), combinations and uses thereof for disease therapy, or a pharmaceutically acceptable salt or solvate thereof, including all tautomers, stereoisomers and polymorphs thereof wherein: R1 represents C2-8alkyl; C2-8alkenyl; —(C1-6alkyl)-aryl; —(C1-6alkyl)-heteroaryl; —(C1-6alkyl)-carbocyclyl; —(C1-6alkyl)-heterocyclyl; -aryl; -heteroaryl; -carbocyclyl or -heterocyclyl; wherein said aryl or heteroaryl groups may be optionally substituted by one or more substituents selected from, C1-4alkyl, C1-4-fluoroalkyl, C1-4alkoxy, C1-4-fluoroalkoxy, hydroxy, —SO2(C1-4alkyl), —SO2N(C1-4alkyl)(C1-4alkyl), —SOC1-4alkyl, —SOC3-6cycloalkyl —C(O)O(C1-4alkyl), benzyloxy and phenyl; and wherein said carbocyclyl and heterocyclyl groups may be optionally substituted by one or more substituents selected from —C1-4 alkyl, —C1-4 alkoxy, hydroxyl, halogen and oxo; R2 represents H; C1-4alkyl or halogen; R3 represents H; C1-4alkyl or halogen; and R4 represents H; C1-4alkyl or halogen.

    摘要翻译: 式(I)的化合物,其用于疾病治疗的组合和用途,或其药学上可接受的盐或溶剂合物,包括所有互变异构体,立体异构体和多晶型物,其中:R 1表示C 2- 8烷基; C 2〜C 8链烯基; - (C 1-6烷基) - 芳基; - (C 1-6烷基) - 杂芳基; - (C 1-6烷基) - 碳环基; - (C 1-6烷基) - 杂环基; 芳基 杂芳基 碳环基或杂环基; 其中所述芳基或杂芳基可以任选被一个或多个选自C 1-4 - 烷基,C 1-4 - 氟代烷基,C 1 - -4个烷氧基,C 1-4 1-4氟烷氧基,羟基,-SO 2(C 1-4烷基), - SO 2 N(C 1-4烷基)(C 1-4烷基),-SOC 1-4, 烷基,-SOC 3 -C 3-6环烷基-C(O)O(C 1-4烷基),苄氧基和苯基; 并且其中所述碳环基和杂环基可以任选被一个或多个选自-C 1-4烷基,-C 1-4烷氧基,羟基,卤素和 氧代 R 2表示H; C 1-4烷基或卤素; R 3表示H; C 1-4烷基或卤素; R 4表示H; C 1-4烷基或卤素。